Bioharvest Sciences (BHST) traded down -2.33 % during a 24 hours period ending at 09:58 PM Central Europe on Tuesday 27th. One Bioharvest Sciences stock can currently be bought for about USD 1.68 on popular exchanges. Current supply of Bioharvest Sciences stocks is 23.1 mn. Bioharvest Sciences has a current market capitalization of USD 39 mn and approximately USD 27.6 k worth of Bioharvest Sciences was traded on exchanges in the last 24 hours. Since last month end, Bioharvest Sciences has traded 15.86 % up. Simple moving average of last 200 days is at USD 3.31. The highest price of past 52 weeks was recorded at USD 10.21 on 10/29/2025. 52 weeks low was at USD 1.37 on 10/07/2026.

Here is how related stocks have performed in the past 24 hours:

  • Edge Copper (EDCU.TO) traded flat 0 % and now trades at CAD 0.38. Edge Copper has a market capitalisation of CAD 63.6 mn.

  • Altamira Gold (ALTA.V) traded flat 0 % and now trades at CAD 0.23. Altamira Gold has a market capitalisation of CAD 65.4 mn.

  • Base Carbon (7OS.F) traded down -4.76 % and now trades at CAD 0.59. Base Carbon has a market capitalisation of CAD 63.6 mn.

  • Intellistake (ISTK.CN) traded down -7.95 % and now trades at CAD 0.4. Current market capitalisation for Intellistake is CAD 65.2 mn.

  • Leef Brands (LEEF.CN) traded down -2.38 % and now trades at CAD 0.2. Leef Brands has a market capitalisation of CAD 64.2 mn.

About Bioharvest Sciences

BioHarvest Sciences Inc. is a Canadian biotechnology company that specializes in the development of novel plant-based drugs and natural health products. The company operates out of its head office located in Vancouver, British Columbia, Canada. It was incorporated in 1999 and has since been actively involved in the research and development of various biological agents derived from plants and natural sources for therapeutic and wellness applications. BioHarvest Sciences Inc.’s mission is to advance the use of plant-based drugs and natural health products as alternative and complementary treatments to traditional pharmaceuticals, while maintaining the highest possible quality standards.